Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats

Brain Research

Volumn 1123, Issue 1, 2006, Pages 51-59

  Mark, Gregory P ^a   Kinney, Anthony E ^a   Grubb, Michele C ^a   Zhu, Xiaoman ^a   Finn, Deborah A ^a,b   Mader, Sarah L ^a   Berger, S Paul ^a,b   Bechtholt, Anita J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Addiction; Cholinergic system; Mesolimbic dopamine system; Muscarinic receptor; Pirenzepine; Progressive ratio

Indexed keywords

COCAINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; OXOTREMORINE DERIVATIVE; OXOTREMORINE METHIODIDE; PIRENZEPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CEREBROSPINAL FLUID ANALYSIS; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; EXPERIMENTAL RAT; FOOD INTAKE; MALE; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; MALE; MICROINJECTIONS; MUSCARINIC AGONISTS; NUCLEUS ACCUMBENS; OXOTREMORINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; REWARD; SELF ADMINISTRATION;

ANIMALIA;

EID: 33751268159     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.029     Document Type: Article

References (61)

1. Bechtholt A.J., and Mark G.P. Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology 162 (2002) 178-185
2. Berlanga M.L., Olsen C.M., Chen V., Ikegami A., Herring B.E., Duvauchelle C.L., and Alcantara A.A. Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120 (2003) 1149-1156
3. Buhrich N., Weller A., and Kevans P. Misuse of anticholinergic drugs by people with serious mental illness. Psychiatr. Serv. 51 (2000) 928-929
4. Bymaster F.P., Heath I., Hendrix J.C., and Shannon H.E. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J. Pharmacol. Exp. Ther. 267 (1993) 16-24
5. Caine S.B., Lintz R., and Koob G.F. Intravenous drug self-administration techniques in animals. In: Sahgal A. (Ed). Behavioral Neuroscience; A Practical Approach (1993), Oxford Univ. Press, New York 117-143
6. Corrigall W.A., Coen K.M., Zhang J., and Adamson L. Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine. Psychopharmacology 160 (2002) 198-205
7. de Rover M., Lodder J.C., Kits K.S., Schoffelmeer A.N., and Brussaard A.B. Cholinergic modulation of nucleus accumbens medium spiny neurons. Eur. J. Neurosci. 16 (2002) 2279-2290
8. Di Chiara G., Morelli M., and Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17 (1994) 228-233
9. Fink-Jensen A., Fedorova I., Wortwein G., Woldbye D.P., Rasmussen T., Thomsen M., Bolwig T.G., Knitowski K.M., McKinzie D.L., Yamada M., Wess J., and Basile A. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J. Neurosci. Res. 74 (2003) 91-96
10. Garvey D.S., Wasicak J.T., Chung J.Y., Shue Y.K., Carrera G.M., May P.D., McKinney M.M., Anderson D., Cadman E., Vella-Rountree L., et al. Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors. J. Med. Chem. 35 (1992) 1550-1557
11. Gil D.W., and Wolfe B.B. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. J. Pharmacol. Exp. Ther. 232 (1985) 608-616
12. Goldstein R.Z., Alia-Klein N., Leskovjan A.C., Fowler J.S., Wang G.J., Gur R.C., Hitzemann R., and Volkow N.D. Anger and depression in cocaine addiction: association with the orbitofrontal cortex. Psychiatry Res. 138 (2005) 13-22
13. Gralewicz S., Lutz P., Wiaderna D., and Tomas T. Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Brain Res. 147 (2003) 163-173
14. Gulley J.M., and Zahniser N.R. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur. J. Pharmacol. 479 (2003) 139-152
15. Hagan J.J., Tonnaer J.A.D.M., Rijk H., Broekkamp C.L.E., and van Delft A.M.L. Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity. Brain Res. 410 (1987) 69-73
16. Heidbreder C.A., and Shippenberg T.S. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24 (1996) 182-192
17. Hikida T., Kaneko S., Isobe T., Kitabatake Y., Watanabe D., Pastan I., and Nakanishi S. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc. Natl. Acad. Sci. 98 (2001) 13351-13354
18. Hikida T., Kitabatake Y., Pastan I., and Nakanishi S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl. Acad. Sci. 100 (2003) 6169-6173
19. Ichikawa J., Chung Y.C., Li Z., Dai J., and Meltzer H.Y. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res. 958 (2002) 176-184
20. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Rats self-administer carbachol directly into the nucleus accumbens. Physiol. Behav. 63 (1998) 811-814
21. Itzhak Y., and Martin J.L. Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology 152 (2000) 216-223
22. Janowsky D.S., el-Yousef M.K., Davis J.M., and Sekerke H.J. Antagonistic effects of physostigmine and methylphenidate in man. Am. J. Psychiatry 130 (1973) 1370-1376
23. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 12 (1995) 527-535
24. Le A.D., Wang A., Harding S., Juzytsch W., and Shaham Y. Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psychopharmacology 168 (2003) 216-221
25. Liste I., Bernard V., and Bloch B. Acute and chronic acetylcholinesterase inhibition regulates in vivo the localization and abundance of muscarinic receptors m2 and m4 at the cell surface and in the cytoplasm of striatal neurons. Mol. Cell. Neurosci. 20 (2002) 244-256
26. Macedo D.S., Correia E.E., Vasconcelos S.M., Aguiar L.M., Viana G.S., and Sousa F.C. Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell. Mol. Neurobiol. 24 (2004) 129-136
27. Mansvelder H.D., and McGehee D.S. Cellular and synaptic mechanisms of nicotine addiction. J. Neurobiol. 53 (2002) 606-617
28. Mansvelder H.D., De Rover M., McGehee D.S., and Brussaard A.B. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur. J. Pharmacol. 480 (2003) 117-123
29. Mark G.P., Hajnal A., Kinney A.E., and Keys A.S. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berlin) 143 (1999) 47-53
30. Martin-Fardon R., and Weiss F. BTCP is a Potent Reinforcer in Rats: Comparison of Behavior Maintained on Fixed- and Progressive-Ratio Schedules vol. 72 (2002) 343-353
31. Maxwell S.E., and Delaney H.D. Designing Experiments and Analyzing data: A Model Comparison Perspective. 2nd ed. (2004), Lawrence Erlbaum Assoc
32. McGregor A., and Roberts D.C. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav. Brain Res. 67 (1995) 75-80
33. McIntyre C.K., Ragozzino M.E., and Gold P.E. Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task. Behav. Brain Res. 95 (1998) 219-226
34. Meredith G.E., and Chang H.T. Synaptic relationships of enkephalinergic and cholinergic neurons in the nucleus accumbens of the rat. Brain Res. 667 (1994) 67-76
35. Messer Jr. W.S., Ngur D.O., Abuh Y.F., Dokas L.A., Ting S.M., Hacksell U., Nilsson B.M., Dunbar P.G., and Hoss W. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain. Chirality 4 (1992) 463-468
36. Moriya H., Takagi Y., Nakanishi T., Hayashi M., Tani T., and Hirotsu I. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci. 64 (1999) 2351-2358
37. Narahashi T., Moriguchi S., Zhao X., Marszalec W., and Yeh J.Z. Mechanisms of action of cognitive enhancers on neuroreceptors. Biol. Pharm. Bull. 27 (2004) 1701-1706
38. Noronha-Blob L., Canning B., Costello D., and Kinnier W.J. Selective agents for muscarinic receptors linked to phosphoinositide breakdown. Eur. J. Pharmacol. 154 (1988) 161-167
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press
40. Ranaldi R., and Woolverton W.L. Self-administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology 161 (2002) 442-448
41. Rasmussen T., Sauerberg P., Nielsen E.B., Swedberg M.D., Thomsen C., Sheardown M.J., Jeppesen L., Calligaro D.O., DeLapp N.W., Whitesitt C., Ward J.S., Shannon H.E., Bymaster F.P., and Fink-Jensen A. Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice. Eur. J. Pharmacol. 402 (2000) 241-246
42. Roberts D.C. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 32 (1989) 43-47
43. Roberts D.C. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol. Behav. 86 (2005) 18-20
44. Roberts D.C.S., and Richardson N.R. Self-administration of psychomotor stimulants using progressive ratio schedules of reinforcement. In: Wu P., Boulton A., and Baker G.B. (Eds). Neuromethods: Animal Models of Drug Addiction (1992), Humana Press, Clifton, NJ 263-269
45. Roberts D.C., Loh E.A., and Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97 (1989) 535-538
46. Schroeder J.P., and Packard M.G. Posttraining intra-basolateral amygdala scopolamine impairs food- and amphetamine-induced conditioned place preferences. Behav. Neurosci. 116 (2002) 922-927
47. See R.E., McLaughlin J., and Fuchs R.A. Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience 117 (2003) 477-483
48. Shannon H.E., and Peters S.C. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J. Pharmacol. Exp. Ther. 255 (1990) 549-553
49. Sharkey J., Ritz M.C., Schenden J.A., Hanson R.C., and Kuhar M.J. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J. Pharmacol. Exp. Ther. 246 (1988) 1048-1052
50. Shippenberg T.S., Heidbreder C., and Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299 (1996) 33-39
51. Smith A.D., and Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13 (1990) 259-265
52. Smith J.E., Co C., Yin X., Sizemore G.M., Liguori A., Johnson III W.E., and Martin T.J. Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci. Biobehav. Rev. 27 (2004) 841-850
53. Soderpalm B., Ericson M., Olausson P., Blomqvist O., and Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav. Brain Res. 113 (2000) 85-96
54. Sousa F.C., Gomes P.B., Macedo D.S., Marinho M.M., and Viana G.S. Early withdrawal from repeated cocaine administration upregulates muscarinic and dopaminergic D2-like receptors in rat neostriatum. Pharmacol. Biochem. Behav. 62 (1999) 15-20
55. Spencer D.G.J., Horvath E., and Traber J. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res. 380 (1986) 59-68
56. Thomsen M., Woldbye D.P., Wortwein G., Fink-Jensen A., Wess J., and Caine S.B. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J. Neurosci. 25 (2005) 8141-8149
57. Tonnaer J.A., Ernste B.H., Wester J., and Kelder K. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study. J. Chem. Neuroanat. 1 (1988) 95-110
58. Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Montgomery M.A., Goldsmith R.J., Coleman F.S., Bloch D.A., Leiderman D.B., Singal B.M., Berger P., and Elkashef A. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100 Suppl. 1 (2005) 68-77
59. Yeomans J., Forster G., and Blaha C. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci. 68 (2001) 2449-2456
60. Zachariou V., Caldarone B.J., Weathers-Lowin A., George T.P., Elsworth J.D., Roth R.H., Changeux J., and Picciotto M.R. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 24 (2001) 576-589
61. Zhang W., Yamada M., Gomeza J., Basile A.S., and Wess J. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J. Neurosci. 22 (2002) 6347-6352